|
Highlights of the
week:
For more career opportunities
from various industries, please access Career Axis. Dear Students, The life sciences industry continues to see rapid growth within
the APAC region. With our supportive business environment and ecosystem,
Singapore is a leading hub for biopharma manufacturing, R&D and
commercial operations within the region. At the opening of the new facility of Singapore-based biomedical
start-up Hummingbird Bioscience back in September, DPM Mr Heng Swee Keat had shared that the biomedical sciences are now a
key pillar in Singapore's manufacturing economy. Just last month, Global medical technology company ResMed has officially opened its
largest advanced manufacturing centre in Singapore.
Senior Minister Mr Tharman Shanmugaratnam, who was the guest-of-honour
at the plant’s opening, cited that the sector is poised to grow further,
especially in areas such as diagnostics, automated solutions that can reduce
the burden of healthcare workers, and contactless, digitally enabled devices
that can provide predictive insights. Further, despite the tight labour
market and higher labour costs, Chief executive Michael Farrell shared that
the Singapore offers the right talent ResMed needs for data analytics,
material science, materials engineering and
commercial innovation. Bolstered by such increasing biotech investments and
accelerating healthcare research, the biomedical sciences (BMS) industry has
experienced strong growth in recent years, further reinforcing Singapore’s position
as a leading biomedical science hub at the heart of Asia. Additional factors spurring the growth of Singapore’s biomedical
industry include: ·
Significant
increase in public sector funding to fuel growth ·
The
growth of food tech ·
Prevailing
megatrends to drive increased pharmaceutical spending over next decade ·
Healthy
demand for lab space
Source:
EDB Singapore What to watch and keep a lookout for in 2023? ·
Haleon emerges from GSK Consumer Healthcare
Spin-off. ·
Johnson & Johnson
Spins-off Consumer Health Division into Kenvue by 2023 ·
Biotronik expands manufacturing facility and will move into new site in
Kallang in 2023. ·
WuXi Apptech announced to build a new R&D and Manufacturing site in
Singapore. ·
MSD launches new manufacturing facilities in Singapore and
continued investments for innovative medicines and vaccines. ·
Edwards Lifesciences
and Becton Dickinson are also in discussions for possible expansion and
innovation in manufacturing facilities Upcoming Virtual Talk ARUP Insights Forum 2023 - Learn more about
and gain insights to 14 job functions within Arup & Apply for Graduate
Development Programme Graduate Programmes with Application Period Open
Interested to learn more about building a career in this industry?
Simply join my interest groups (in table below) with priority access to
career opportunities and events or click here to book an appointment with me directly.
This week’s e-blast is
prepared by:
Wilson Huang wilson.huang@ntu.edu.sg Biomedical Sciences |
Building & Construction |
|
|||||||||||||||||||||||||||||
|
|
|
|
|
||
|
||
|
|
CONFIDENTIALITY:
This email is intended solely for the person(s) named and may be confidential
and/or privileged. If you are not the intended recipient, please delete it,
notify us and do not copy, use, or disclose its
contents.
Towards a sustainable earth: Print only when necessary. Thank you.